16-27618431-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_015202.5(KATNIP):c.70G>A(p.Ala24Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,611,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_015202.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KATNIP | NM_015202.5 | c.70G>A | p.Ala24Thr | missense_variant | 3/28 | ENST00000261588.10 | NP_056017.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KATNIP | ENST00000261588.10 | c.70G>A | p.Ala24Thr | missense_variant | 3/28 | 1 | NM_015202.5 | ENSP00000261588.4 | ||
KATNIP | ENST00000568258.5 | c.55G>A | p.Ala19Thr | missense_variant | 2/7 | 3 | ENSP00000454884.1 | |||
KATNIP | ENST00000565672.5 | n.34-10230G>A | intron_variant | 3 | ENSP00000455380.1 | |||||
KATNIP | ENST00000618117.1 | c.-39G>A | upstream_gene_variant | 5 | ENSP00000483214.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251462Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135900
GnomAD4 exome AF: 0.0000288 AC: 42AN: 1459646Hom.: 0 Cov.: 29 AF XY: 0.0000386 AC XY: 28AN XY: 726280
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74464
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at